当前位置:首页 - 行情中心 - 罗欣药业(002793) - 财务分析 - 现金流量表

罗欣药业

(002793)

  

流通市值:58.21亿  总市值:58.29亿
流通股本:10.86亿   总股本:10.88亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,842,186,793.321,245,971,833.27645,619,022.372,408,247,579.75
  收到的税费返还2,873,231.11,985,419.74388,168.111,873,125.32
  收到其他与经营活动有关的现金179,164,142.91118,743,992.8923,559,577.3983,422,325.68
  经营活动现金流入小计2,024,224,167.331,366,701,245.9669,566,767.862,503,543,030.75
  购买商品、接受劳务支付的现金420,337,957.89261,481,91694,509,256.35809,620,562.4
  支付给职工以及为职工支付的现金434,482,522.59315,039,515.42154,613,077.37637,735,762.17
  支付的各项税费132,467,559.3989,565,565.4349,822,821.36113,912,696.85
  支付其他与经营活动有关的现金756,820,332.74482,721,870.57214,046,484.11,100,120,945.21
  经营活动现金流出小计1,744,108,372.611,148,808,867.42512,991,639.182,661,389,966.63
  经营活动产生的现金流量净额280,115,794.72217,892,378.48156,575,128.68-157,846,935.88
二、投资活动产生的现金流量:
  收回投资收到的现金---10,900,000
  取得投资收益收到的现金28,529,590.17--73,027.89
  处置固定资产、无形资产和其他长期资产收回的现金净额639,068.35511,346.35188,680.655,316,143.15
  处置子公司及其他营业单位收到的现金净额43,981,454.068,350,651.163,753,026101,652,756.52
  收到的其他与投资活动有关的现金1,350,000450,000450,0001,873,636.14
  投资活动现金流入小计74,500,112.589,311,997.514,391,706.65119,815,563.7
  购建固定资产、无形资产和其他长期资产支付的现金19,598,628.612,254,247.626,109,895.53115,350,874.98
  投资支付的现金8,000,0004,000,0004,000,0005,800,000
  支付其他与投资活动有关的现金3,889,062.713,889,062.71--
  投资活动现金流出小计31,487,691.3120,143,310.3310,109,895.53121,150,874.98
  投资活动产生的现金流量净额43,012,421.27-10,831,312.82-5,718,188.88-1,335,311.28
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,637,3503,637,3503,637,350-
  其中:子公司吸收少数股东投资收到的现金3,637,3503,637,3503,637,350-
  取得借款收到的现金845,500,000323,500,000228,000,000933,671,406.95
  收到其他与筹资活动有关的现金360,004,242.96241,504,242.96115,885,1321,155,485,591.09
  筹资活动现金流入小计1,209,141,592.96568,641,592.96347,522,4822,089,156,998.04
  偿还债务支付的现金1,128,668,242.51579,373,287.5473,000,000820,567,571.32
  分配股利、利润或偿付利息支付的现金38,228,040.2423,963,348.7514,993,753.8162,171,581.03
  其中:子公司支付给少数股东的股利、利润---980,000
  支付其他与筹资活动有关的现金335,234,801.44265,541,493.7378,582,951.451,340,549,180.05
  筹资活动现金流出小计1,502,131,084.19868,878,129.98566,576,705.262,223,288,332.4
  筹资活动产生的现金流量净额-292,989,491.23-300,236,537.02-219,054,223.26-134,131,334.36
四、汇率变动对现金及现金等价物的影响-1,832,533.11-1,277,356.5844,602.692,761,431.2
五、现金及现金等价物净增加额28,306,191.65-94,452,827.94-68,152,680.77-290,552,150.32
  加:期初现金及现金等价物余额289,389,415.42289,389,415.42289,389,415.42579,941,565.74
  期末现金及现金等价物余额317,695,607.07194,936,587.48221,236,734.65289,389,415.42
补充资料:
  净利润-21,996,782--1,052,258,630.89
  资产减值准备--43,055,461.79-314,834,673.36
  固定资产和投资性房地产折旧-76,716,221.45-152,231,787.14
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-76,716,221.45-152,231,787.14
  无形资产摊销-23,140,233.99-40,538,792.29
  长期待摊费用摊销-8,492,308.2-5,809,181.62
  处置固定资产、无形资产和其他长期资产的损失--4,276,148.66--240,869.31
  固定资产报废损失-1,722.53-4,595,962.57
  公允价值变动损失---213,130,913.8
  财务费用-31,473,184.05-62,289,130.59
  投资损失--857,350.34-3,453,844.64
  递延所得税-15,261,871.78-97,532,390.11
  其中:递延所得税资产减少-18,595,087.97-97,759,593.81
    递延所得税负债增加--3,333,216.19--227,203.7
  存货的减少-46,437,682.22--79,286,885.15
  经营性应收项目的减少-224,462,178.82--17,520,790.27
  经营性应付项目的增加--200,269,102.54-81,457,981.73
  其他-13,318,722.52-2,570,459.29
  现金的期末余额-194,936,587.48-289,389,415.42
  减:现金的期初余额-289,389,415.42-579,941,565.74
  现金及现金等价物的净增加额--94,452,827.94--290,552,150.32
公告日期2025-10-282025-08-282025-04-222025-04-22
审计意见(境内)标准无保留意见
TOP↑